Salem Investment Counselors Inc Novo Cure LTD Transaction History

Salem Investment Counselors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 04, 2023	SELL	$16.15 - $42.35 $1,372 - $3,599	-85 Reduced 95.51%	4 $0
Q2 2023 Jul 19, 2023	BUY	$40.29 - $82.51 $402 - $825	10 Added 12.66%	89 $3,000
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $300 - $487	4 Added 5.33%	79 $6,000
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $4,353 - $8,348	75 New	75 $8,000

264

76.5M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.49B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.